OCTOBER 3-5, 2013 AT HILTON BEIRUT HABTOOR GRAND

Transcription

OCTOBER 3-5, 2013 AT HILTON BEIRUT HABTOOR GRAND
Under the High Patronage of His Excellency
the Minister of Public Health Mr. Ali Hassan Khalil
OCTOBER 3-5, 2013 AT HILTON BEIRUT HABTOOR GRAND HOTEL, LEBANON
DEAR COLLEAGUES,
As I write this welcome, we have again a little
turmoil in the region. However, it is important
to remember that we owe it to our patients,
to Lebanon and to the scientific community
to go on. Most of all, we owe it to our faithful
attendees, from many countries of the region,
who look forward every year to this event.
In this spirit, a large debt of gratitude is due to
our sponsors, to the scientific and organizing
committees and to our distinguished speakers.
With their support we have put together a rich
program of very high caliber.
Thank you for your support to the Lebanese
Society of Hematology and Blood transfusion
and to Lebanon.
I am sure we will have a wonderful time and
fruitful meeting.
Miguel R. ABBOUD MD, MHA
President of the Lebanese Society of
Hematology and Blood transfusion
INTERNATIONAL SPEAKERS
LSH SCIENTIFIC COMMITTEE
Günter AUERSWALD MD,PhD GERMANY
Miguel R. ABBOUD MD, MHA
Alain BEAUPLET MD FRANCE
Ali BAZARBACHI MD, PhD, MHA
Yves BERTRAND MD, PhD FRANCE
Berthe CHALHOUB HACHEM MD
Gregory CHENG MD, PhD HONG KONG
Bertrand COIFFIER MD, PhD FRANCE
Thierry FACON MD FRANCE
Ahmad IBRAHIM MD
Nidal JOUMAA MD
Claudia DJAMBAS KHAYAT MD
Peter NOUN MD
Pierre FENAUX MD, PhD FRANCE
Jean Pierre SAAB MD
Ephraim FUCHS MD, MBA USA
Hanady SAMAHA MD
Olivier HERMINE MD, PhD FRANCE
Ali TAHER MD, PhD, FRCP
Alfonso IORIO MD, PhD, FRCP CANADA
Rezan KADIR MD, FRCS, MRCOG UL
LSH EXECUTIVE COMMITTEE
Mohamed KHARFAN DABAJA MD USA
Miguel R. ABBOUD MD, MHA PRESIDENT
Odile OBERLIN MD FRANCE
Isaac ODAME MB, ChB, MRCP, FRCPath, FRCPC CANADA
Yves PIQUET MD FRANCE
Alok STRIVASTAVA MD, FRACP, FRCPA, FRCP INDIA
Hanady SAMAHA MD VICE PRESIDENT
Peter NOUN MD PAST PRESIDENT
Berthe CHALHOUB HACHEM MD SECRETARY
Claudia DJAMBAS KHAYAT MD TREASURER
Ahmad IBRAHIM MD MEMBER
René TARDIVEL MD FRANCE
Nidal JOUMAA MD MEMBER
Swee Lay THEIN MB, BS, FRCPath, FRCP, DSC, FMedSci UK
Jean Pierre SAAB MD MEMBER
THURSDAY OCTOBER 3
13:30-14:00
REGISTRATION
14:00-14:30
OPENING CEREMONY
Welcome note: President of the Lebanese Society of Hematology
and Blood transfusion Miguel R. ABBOUD
Word of the Lebanese Minister of Public Health Mr. Ali Hassan KHALIL
14:30-16:00
TRANSFUSION SESSION:LAUNCHING OF NEW NATIONAL GUIDELINES*
Organized by:
The Lebanese Ministry of Public Health
In collaboration with:
Lebanese Society of Hematology and Blood Transfusion
Lebanese Syndicate of Clinical Pathologists
Introduction Rita FEGHALI
Word from the Department of Health and “Etablissement Français du sang - EFS”
Alain BEAUPLET
Implementation of good manufacturing practices in blood transfusion
in Lebanon Yves PIQUET
Good manufacturing practices in blood component preparation René TARDIVEL
Update on emerging pathogens in blood transfusion Yves PIQUET
Efficacy of platelet transfusion in hematology René TARDIVEL
* Simultaneous translation available
16:00-17:30
EDUCATIONAL SESSION I: BLEEDING DISORDERS IN WOMEN
Joint session with Lebanese Society for Obstetrics and Gynecology
In Collaboration with World Federation of Hemophilia
16:00-16:30
Women with bleeding disorders – pregnancy complications and management
Rezan KADIR
16:30-17:00
DDAVP & tranexamic acid revisited Günter AUERSWALD
17:00-17:30
Inherited bleeding disorders in women – improving diagnosis and treatment
Rezan KADIR
17:30-18:00
COFFEE BREAK
18:00-18:40
NOVARTIS ONCOLOGY SYMPOSIUM
Recent Advances in the Management of Non-Transfusion-Dependent
Thalassemia (NTDT) Ali TAHER
18:40-19:10
EDUCATIONAL SESSION II: HEMOGLOBINOPATHIES
18:40-19:10
Global Network in Sickle Cell Disease Isaac ODAME
FRIDAY OCTOBER 4
09:00-10:30
EDUCATIONAL SESSION III: HEMOGLOBINOPATHIES
09:00-09:30
New clinical trials in Sickle Cell Disease Swee Lay THEIN
09:30-10:00
Global perspectives in Sickle Cell Disease Isaac ODAME
10:00-10:30
Stem cells Transplant in Hemoglobinopathies Ephraim FUCHS
10:30-11:00
COFFEE BREAK
11:00-12:30
EDUCATIONAL SESSION IV: HEMOPHILIA STATE OF THE ART TREATMENT
In Collaboration with World Federation of Hemophilia
11:00-11:30
Assessment need for good care Alok STRIVASTAVA
11:30-12:00
Building evidence based optimal treatment in hemophilia: where are we at?
An epidemiologic perspective Alfonso IORIO
12:00-12:30
Joint health in Hemophilia Alok STRIVASTAVA
12:30-13:15
SPECIAL SYMPOSIUM
Evolving New Opportunities in Hemophilia Günter AUERSWALD
Sponsored with an unrestricted grant from Novo Nordisk
13:15-14:30
LUNCH
14:30-16:00
EDUCATIONAL SESSION V: PEDIATRIC LYMPHOMA
14:30-15:00
Hodgkin Lymphoma in Pediatric Patients Odile OBERLIN
15:00-15:30
Lymphoblastic lymphoma in Pediatric patients Yves BERTRAND
15:30-16:00
Late effects of therapy in Pediatric Hodgkin Lymphoma Odile OBERLIN
16:00-16:50
EDUCATIONAL SESSION VI: PLATELETS AND COAGULATION
16:00-16:25
Prevention of recurrent VTE: optimal duration or personalized treatment?
Afonso IORIO
16:25-16:50
Investigational agents in Aplastic Anemia Gregory CHENG
16:50-17:30
COFFEE BREAK
17:30-18:15
GSK CHRONIC ITP SYMPOSIUM Gregory CHENG
18:15-19:00
ROCHE SYMPOSIUM Speaker TBD
SATURDAY OCTOBER 5
09:00-10:00
EDUCATIONAL SESSION VII: MULTIPLE MYELOMA
09:00-09:30
First line therapy in Multiple Myeloma Mohamad Kharfan DABAJA
09:30-10:00
Management of relapse-refractory multiple myeloma Thierry FACON
10:00-12:00 EDUCATIONAL SESSION VIII: LEUKEMIA AND MYELODYSPLASIA
10:00-10:30
State of the art management of myelodysplasia Pierre FENAUX
10:30-11:00
Pediatric ALL: update Yves BERTRAND
11:00-11:30
Treatment of acute promyelocytic leukemia: where do we stand? Pierre FENAUX
11:30-12:00
New drugs in CLL Mohamad Kharfan DABAJA
12:00-12:30
COFFEE BREAK
12:30-14:00
EDUCATIONAL SESSION IX: ADULT LYMPHOMA
12:30-13:00
Diffuse large B cell lymphoma Bertrand COIFFIER
13:00-13:30
Mantle cell lymphoma Olivier HERMINE
13:30-14:00
New drugs in lymphoma Bertrand COIFFIER
14:00-15:00
LUNCH
15:00-16:00
EDUCATIONAL SESSION X: PRESIDENTIAL SYMPOSIUM
15:00-15:30
Haploidentical Bone Marrow Transplants: From bench to bedside Ephraim FUCHS
15:30-16:00
Infectious Complications in BMT, Focus on fungal infections Speaker TBD
16:00-16:30
COFFEE BREAK
16:30-17:30
PRESIDENTIAL SYMPOSIUM
16:30-17:00
Modulation of fetal Hemoglobin Swee Lay THEIN
17:00-17:30
Basic Science lecture: Pathophysiology of thalassemia Olivier HERMINE
The Lebanese Society of Hematology and Blood Transfusion wishes to express its gratitude to the following
companies for their generous contribution:
GOLD SPONSORS
SILVER SPONSOR
OTHER SPONSORS
Astra Zeneca
Merck Sharp and Dohme
Benta Pharma Industries BPI
Pacific Pharma S.A.L.
Boehringer Ingelheim
Georges N. Khoriaty Foundation
Glaxo Smithkline
Janssen
Pharmamed
Pierre Fabre Medicament - Oncology Division
Pfizer
Khayat-Kanaan for Medical Equipment
Sanofi
LFB Biomedicaments
Union Pharmaceutique D’orient s.a.l
www.lshbt.org